These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10211868)

  • 1. Differences in the hepatobiliary transport of two quinolone antibiotics, grepafloxacin and lomefloxacin, in the rat.
    Sasabe H; Kato Y; Terasaki T; Tsuji A; Sugiyama Y
    Biopharm Drug Dispos; 1999 Apr; 20(3):151-8. PubMed ID: 10211868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carrier-mediated hepatic uptake of quinolone antibiotics in the rat.
    Sasabe H; Terasaki T; Tsuji A; Sugiyama Y
    J Pharmacol Exp Ther; 1997 Jul; 282(1):162-71. PubMed ID: 9223551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereoselective hepatobiliary transport of the quinolone antibiotic grepafloxacin and its glucuronide in the rat.
    Sasabe H; Kato Y; Tsuji A; Sugiyama Y
    J Pharmacol Exp Ther; 1998 Feb; 284(2):661-8. PubMed ID: 9454812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carrier-mediated mechanism for the biliary excretion of the quinolone antibiotic grepafloxacin and its glucuronide in rats.
    Sasabe H; Tsuji A; Sugiyama Y
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1033-9. PubMed ID: 9495864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible involvement of P-glycoprotein in the biliary excretion of grepafloxacin.
    Zhao YL; Cai SH; Wang L; Kitaichi K; Tatsumi Y; Nadai M; Yoshizumi H; Takagi K; Takagi K; Hasegawa T
    Clin Exp Pharmacol Physiol; 2002 Mar; 29(3):167-72. PubMed ID: 11906478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatobiliary transport kinetics of HSR-903, a new quinolone antibacterial agent.
    Murata M; Tamai I; Sai Y; Nagata O; Kato H; Sugiyama Y; Tsuji A
    Drug Metab Dispos; 1998 Nov; 26(11):1113-9. PubMed ID: 9806954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiologically-based pharmacokinetic analysis of grepafloxacin.
    Nakajima Y; Hattori K; Shinsei M; Matsunaga N; Iizasa H; Sasabe H; Akiyama H; Miyanmoto G; Nakashima E
    Biol Pharm Bull; 2000 Sep; 23(9):1077-83. PubMed ID: 10993208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carrier-mediated uptake of grepafloxacin, a fluoroquinolone antibiotic, by the isolated rat lung cells.
    Sasabe H; Kato Y; Suzuki T; Itose M; Miyamoto G; Sugiyama Y
    Drug Metab Pharmacokinet; 2005 Dec; 20(6):491-5. PubMed ID: 16415534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism for the tissue distribution of grepafloxacin, a fluoroquinolone antibiotic, in rats.
    Suzuki T; Kato Y; Sasabe H; Itose M; Miyamoto G; Sugiyama Y
    Drug Metab Dispos; 2002 Dec; 30(12):1393-9. PubMed ID: 12433809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung tissue distribution after intravenous administration of grepafloxacin: comparative study with levofloxacin.
    Yamamoto H; Koizumi T; Hirota M; Kaneki T; Ogasawara H; Yamazaki Y; Fujimoto K; Kubo K
    Jpn J Pharmacol; 2002 Jan; 88(1):63-8. PubMed ID: 11855679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New quinolone, grepafloxacin, inhibits Cl- secretion across bovine airway epithelium in culture.
    Kanoh S; Tamaoki J; Kondo M; Nagai A
    Respirology; 2001 Mar; 6(1):51-6. PubMed ID: 11264763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transporter-mediated hepatic uptake of ulifloxacin, an active metabolite of a prodrug-type new quinolone antibiotic prulifloxacin, in rats.
    Yagi Y; Aoki M; Iguchi M; Shibasaki S; Kurosawa T; Kato Y; Tsuji A
    Drug Metab Pharmacokinet; 2007 Oct; 22(5):350-7. PubMed ID: 17965518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Phototoxicity studies of pazufloxacin mesilate, a novel parenteral quinolone antimicrobial agent--in vitro and in vivo studies].
    Nagasawa M; Nakamura S; Miyazaki M; Nojima Y; Hayakawa H; Kawamura Y
    Jpn J Antibiot; 2002 Jun; 55(3):259-69. PubMed ID: 12199110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of antacid on absorption of the quinolone lomefloxacin.
    Shimada J; Shiba K; Oguma T; Miwa H; Yoshimura Y; Nishikawa T; Okabayashi Y; Kitagawa T; Yamamoto S
    Antimicrob Agents Chemother; 1992 Jun; 36(6):1219-24. PubMed ID: 1329615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of pharmacokinetics of grepafloxacin in type 2 diabetic rats.
    Watanabe M; Kobayashi M; Ogura J; Takahashi N; Yamaguchi H; Iseki K
    J Pharm Pharm Sci; 2014; 17(1):25-33. PubMed ID: 24735760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of grepafloxacin.
    Efthymiopoulos C
    J Antimicrob Chemother; 1997 Dec; 40 Suppl A():35-43. PubMed ID: 9484872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetics of norfloxacin and lomefloxacin in aqueous humour analysed by microdialysis].
    Sato H; Fukuda S; Inatomi M; Koide R; Uchida N; Kanda Y; Kiuchi Y; Oguchi K
    Nippon Ganka Gakkai Zasshi; 1996 Jul; 100(7):513-9. PubMed ID: 8741334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration.
    Okuyama Y; Momota K; Morino A
    Arzneimittelforschung; 1997 Mar; 47(3):276-84. PubMed ID: 9105546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study on salivary distribution of fluoroquinolones in rats.
    Li Q; Naora K; Hirano H; Okunishi H; Iwamoto K
    Biol Pharm Bull; 2002 Aug; 25(8):1084-9. PubMed ID: 12186414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Grepafloxacin pharmacokinetics in individuals with hepatic dysfunction.
    Efthymiopoulos C; Bramer SL; Maroli A; Flaherty JF; Wolfe E; Bass N; Somberg K
    Clin Pharmacokinet; 1997; 33 Suppl 1():25-31. PubMed ID: 9433653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.